Vanda Pharmaceuticals (VNDA) Cash from Investing Activities Growth (5y) (2015 - 2026)
Vanda Pharmaceuticals (VNDA) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Vanda Pharmaceuticals | 310.98 Mn | 108.67 Mn | 48.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 209.72% |
| Dec 31, 2025 | 36.21% |
| Sep 30, 2025 | 19.59% |
| Jun 30, 2025 | -49.98% |
| Mar 31, 2025 | 16.68% |
| Dec 31, 2024 | 21.44% |
| Sep 30, 2024 | 23.47% |
| Jun 30, 2024 | -5.36% |
| Mar 31, 2024 | 12.95% |
| Dec 31, 2023 | -22.60% |
| Sep 30, 2023 | 42.94% |
| Jun 30, 2023 | -13.52% |
| Mar 31, 2023 | 62.93% |
| Dec 31, 2022 | 59.26% |
| Sep 30, 2022 | -43.24% |
| Jun 30, 2022 | -20.15% |
| Mar 31, 2022 | 21.36% |
| Dec 31, 2021 | -39.04% |
| Sep 30, 2021 | -55.20% |
| Jun 30, 2021 | -20.78% |